Competence Centre Programme

Bio-Competence Centre of Healthy Dairy Products


PÜ E-Piim
Animal Breeders’ Association of Estonia
OÜ Starter ST
Estonian University of Life Sciences
University of Tartu

Foundation of the Competence Centre is a result of implementation of program of Enterprise Estonia. The main activity of  centres is  to implement research of universities to provide and support programmes targeted towards enterpreneurs.

Main objective of Bio-Competence Centre of Healthy Dairy Products is to develop in cooperation of universities and enterprises the technologies to produce raw milk suitable for improvement of cheese yield and biotechnological production of healthy dairy products with additional bioquality. The implementation of results of planned research helps to increase the innovativity and competetiveness of Estonian dairy industry.

Development area No 1

Altering raw milk composition through the feeding technologies and breeding strategies.

Objective: To improve raw milk composition through feeding technologies and breeding strategies with the aim of enhance production of cheese and other healthy dairy products.

Development area No 2

Development of strategies of milk products with enhanced biological value.

Using biotechnological methods elaboration of  anti-infectious and anti-allergic probiotic healthy milk products of  high quality.

Selection of probiotic lactobacilli with  suitable properties for designing of milk products for prevention of enteric infections and allergy. Clinical testing of the properties of these products.


Ene Tammsaar
Phone: +372 731 3403
GSM: +372 516 4210


Competence Centre on Reproductive Medicine and Biology


University of Tartu
Tallinn University
Estonian University of Life Sciences
Asper Biotech
Genomic Toolbox
TBD Biodiscovery
Tartu Biotechnology Park
Nova Vita Clinic
Tartu University Hospital
Elite Clinic
Animal Breeder's Association of Estonia

Competence Centre on Reproductive Medicine and Biology (CCRMB) focuses on:

•novel approaches for human infertility diagnostics and treatment
•human and animal assisted reproductive technologies

CCRMB was founded as a consortium consisting of academia, leading biotechnology enterprises and human/veterinary clinics in Estonia (in total 13 partners). The aim of CCRMB is through collaboration to create synergy between all partners in order to establish a platform for new opportunities to develop innovative technologies as well as to boost commercialization of scientific achievements.

Development area No1. Novel approaches for human infertility diagnostics

Infertility is defined as the inability to conceive after regular unprotected sexual intercourse for 1 year. Based on population surveys the prevalence of infertility ranges up to 20%, thus posing a widespread health problem. The reasons for couple’s infertility can broadly be divided between female- and male-related problems, while in notable number of cases the actual cause for the infertility remains unexplained. Diagnostics of infertility has recently been spurred by technological achievements within the field of biomedicine. The advanced in vivo and ex vivo tissue imaging technologies, high-throughput (HTP), reliable and cost-effective human genetics, genomics, post-genomics and immunology approaches hold great hope to revolutionize the infertility diagnostics. This development area seeks to implement latest breakthrough biomedical technologies to update the current possibilities for female and male infertility diagnostics.

Development area No 2. Advances for human and animal assisted reproductive technologies

This development area focuses on human and animal ART. Although being technologically comparable, the human ART is practiced to overcome couple’s infertility, while with animals it is used to improve the herd’s quality. However, both activities have become steadily more and more popular and account for substantial proportions of reproductive health care and biotechnology sectors in clinical and veterinary medicine, respectively. Moreover, despite the already active use, both markets hold even greater promise for future growth. For these reasons, the technologies and devices necessary for solving the most cumbersome obstacles in front of human and animal ART are impatiently waited and possess the inherent potential to be commercially beneficial.

Development area No 3. Microecological approaches for human reproductive biomedicine

This development area will focus on the understanding of the individually different microbiota of genital tract in both men and women to define normal microbial ecology in an elaborate study using multiple approaches. Based on this knowledge, the assessment of microecological relations in this organ system will be performed in case of microecological disorders (bacterial vaginosis and prostatitis). Moreover, our comparative studies will provide unique information about genital tract microflora of the couples in order to reveal how these imbalanced human-microbe relations affect the partner’s microbiota. This data set may open several new prospects to seek approaches and create tools to diagnose and restore, if necessary, the microecological balance in genital tract using microflora-based treatment and prophylactic schemes.


Ülle Jaakma
Phone: +372 731 3466
GSM: +372 528 8468